Drug-Resistant Tuberculosis Treatment Market Set to Expand at 4.9% CAGR
Market Overview The Global Drug-Resistant Tuberculosis Treatment Market is projected to experience notable growth over the next decade. It is expected to expand from USD 1,117.1 million in 2023 to approximately USD 1,802.4 million by 2033, reflecting a Compound Annual Growth Rate (CAGR) of 4.9% during the forecast period from 2024 to 2033. This market growth is driven by several critical factors, including the rising prevalence of drug-resistant tuberculosis (TB), advancements in treatment options, and increasing global health initiatives aimed at combating TB. The Drug-Resistant Tuberculosis Treatment Market research report delivers essential data, offering clients the insights necessary for making…
- Date: May 22, 2024
- Author: Thomas Bretz
- Category: PharmiWeb